These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33714278)

  • 1. Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
    Mohammedi K; Préaubert N; Cariou T; Rigalleau V; Foussard N; Piazza L; Bairras-Martin C; Couffinhal T; Bezin J; Benard A
    Cardiovasc Diabetol; 2021 Mar; 20(1):63. PubMed ID: 33714278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database.
    Blin P; Darmon P; Henry P; Guiard E; Bernard MA; Dureau-Pournin C; Maizi H; Thomas-Delecourt F; Lassalle R; Droz-Perroteau C; Moore N
    Cardiovasc Diabetol; 2021 Nov; 20(1):229. PubMed ID: 34823531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management.
    Minami HR; Itoga NK; George EL; Garcia-Toca M
    J Vasc Surg; 2021 Dec; 74(6):2030-2039.e2. PubMed ID: 34175383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
    Ferrannini G; De Bacquer D; Vynckier P; De Backer G; Gyberg V; Kotseva K; Mellbin L; Norhammar A; Tuomilehto J; Wood D; Rydén L;
    Cardiovasc Diabetol; 2021 Feb; 20(1):38. PubMed ID: 33573665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
    Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
    Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.
    Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL
    JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
    Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
    Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medical value and cost-effectiveness of an exercise test for sport preparticipation evaluation in asymptomatic middle-aged white male and female athletes.
    Chevalier L; Kervio G; Doutreleau S; Mathieu JP; Guy JM; Mignot A; Corneloup L; Passard F; Laporte T; Girard-Girod A; Hennebert O; Bernadet P; Vincent-Chevalier MP; Gencel L; Carré F
    Arch Cardiovasc Dis; 2017 Mar; 110(3):149-156. PubMed ID: 28117245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study.
    Mohammedi K; Fauchier L; Quignot N; Khachatryan A; Banon T; Kapnang R; Kikuchi K; Ren H; Massien C; Vigié L; Larsen S; Sibon I
    Cardiovasc Diabetol; 2024 May; 23(1):183. PubMed ID: 38812009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GEnetic Syntax Score: a genetic risk assessment implementation tool grading the complexity of coronary artery disease-rationale and design of the GESS study.
    Vizirianakis IS; Chatzopoulou F; Papazoglou AS; Karagiannidis E; Sofidis G; Stalikas N; Stefopoulos C; Kyritsis KA; Mittas N; Theodoroula NF; Lampri A; Mezarli E; Kartas A; Chatzidimitriou D; Papa-Konidari A; Angelis E; Karvounis Η; Sianos G
    BMC Cardiovasc Disord; 2021 Jun; 21(1):284. PubMed ID: 34103005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study.
    Venuraju SM; Lahiri A; Jeevarethinam A; Cohen M; Darko D; Nair D; Rosenthal M; Rakhit RD
    Cardiovasc Diabetol; 2019 Apr; 18(1):51. PubMed ID: 31014330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
    Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
    Emery C; Torreton E; Briere JB; Evers T; Fagnani F
    J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
    [No Abstract]   [Full Text] [Related]  

  • 17. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Arnold SV; Bhatt DL; Barsness GW; Beatty AL; Deedwania PC; Inzucchi SE; Kosiborod M; Leiter LA; Lipska KJ; Newman JD; Welty FK;
    Circulation; 2020 May; 141(19):e779-e806. PubMed ID: 32279539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
    Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
    Trials; 2010 Feb; 11():16. PubMed ID: 20170482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.